Literature DB >> 29432961

Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment.

Andreas Wollenberg1, Lieneke Ariens2, Stephan Thurau3, Chantal van Luijk4, Marlene Seegräber5, Marjolein de Bruin-Weller2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29432961     DOI： 10.1016/j.jaip.2018.01.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  28 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 2.  A review of dupilumab in the treatment of atopic diseases.

Authors:  Quinn Thibodeaux; Mary Patricia Smith; Karen Ly; Kristen Beck; Wilson Liao; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2019-03-27       Impact factor: 3.452

3.  Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae.

Authors:  Filippos Vingopoulos; Douglas R Lazzaro
Journal:  Int Med Case Rep J       Date:  2020-07-28

4.  Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.

Authors:  Alison D Treister; Cheryl Kraff-Cooper; Peter A Lio
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

5.  Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up.

Authors:  Austin Bohner; Christina Topham; Jennifer Strunck; Dylan Haynes; Molly Brazil; John Clements; Eric Simpson; Winston Chamberlain
Journal:  Cornea       Date:  2021-05-01       Impact factor: 3.152

6.  Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis.

Authors:  Adrien Maudinet; Sandrine Law-Koune; Claire Duretz; Audrey Lasek; Philippe Modiano; Thi Ha Chau Tran
Journal:  Ophthalmol Ther       Date:  2019-06-22

7.  Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase.

Authors:  Sunny Park; Jung Hyun Lee; Ji Hyun Park; So Hyang Park; Song Yi Park; Yong Woo Jung; Soo An Choi
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

8.  Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process.

Authors:  Jacob P Thyssen; Steffen Heegaard; Lena Ivert; Anita Remitz; Tove Agner; Marjolein De Bruin-Weller; Theis Huldt-Nystrøm; Laura Korhonen; Lina U Ivert; Pekka Leinonen; Johanna Mandelin; Tore Särnhult; Thomas Schopf; Eirik Sundlisæter; Simon F Thomsen; Thrasyvoulos Tzellos; Christian Vestergaard; Laura von Kobyletzki; Maria Bradley
Journal:  Acta Derm Venereol       Date:  2020-09-16       Impact factor: 3.875

Review 9.  A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis.

Authors:  Chan Ho Na; Wenelia Baghoomian; Eric L Simpson
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

Review 10.  Potential Biomarkers for Allergic Conjunctival Diseases.

Authors:  Neeta Roy; Shir Levanon; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2020-03       Impact factor: 3.152
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.